Open company graph database — free web & API
Login

Nichimo Biotics Inc.

ニチモウバイオティックス株式会社NICHIMO BIOTICS CO.,LTD.Alias
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
17
Related companies
1
§01

Basic information

BASIC
Head office
1-6-15 Hamamatsucho, Minato-ku, Tokyo 105-0013, VORT Hamamatsucho I 7F
Chief executive
Akihiro Kitaya
Capital
100,000,000 JPY
Employees (non-consolidated)
Employees (consolidated)
17 people
Start date
1999-01-29
End date
§02

Websites

1 DOMAINS
§03

Business

5
Production of fermented soybean germManufacturing and sales of health food ingredientsManufacturing and sales of health foodsManufacturing and sales of cosmeticsManufacturing and sales of supplements
§04

Related companies

1 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Nichimo Logistics Co., Ltd.
Group Parent
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

65 EVENTS

From 1990, started research on soybeans at Nichimou Corporation aiming for use in aquacultureSources

Established as a company producing fermented soybean germSources

Started production of 'Imsoy', a mixed feed of fermented soybean germ and koji mold soy fermentation cultureSources

In January 1999, established 'Nichimou Biotics Corporation' as a producer of fermented soybean germSources

Obtained manufacturing patent in the United StatesSources

In March 1999, obtained a manufacturing patent in the United StatesSources

A new business division called 'Biotics Division' was established at Nichimo, and the fermented soybean business officially startedSources

Commercialized isoflavone aglycone extracted from fermented soybean germ (product name 'AglyMax') and began supplying to health food manufacturersSources

In April 1999, Nichimou established the Biotics Division as a new business unit, launching a full‑scale effort in fermented soybean products.Sources

In April 1999, the agricon‑type isoflavone material extracted from fermented soybean germ was commercialized as "AglyMax" and supplied to health food manufacturers.Sources

Obtained manufacturing patent in JapanSources

In December 1999, a manufacturing method patent was obtained in Japan.Sources

Launched our own brand supplement 'Isoracon'Sources

In June 2001, the company’s own brand supplement "IsoLacon" was released.Sources

Obtained manufacturing patent in EuropeSources

In October 2002, a manufacturing method patent was obtained in Europe.Sources

Launched pharmacy-oriented supplement 'Phytrogen'Sources

In October 2003, the pharmacy‑targeted supplement "Phytogen" was released.Sources

Launched supplement 'LifeMax' for middle-aged and older menSources

Launched medical institution-oriented supplement 'Dr. AglyMax®'Sources

In March 2004, the supplement "LifeMax" for middle‑aged and older men was released.Sources

In March 2004, the supplement "Dr. AglyMax" for medical institutions was released.Sources

Achieved ISO9001 certification at Nichimo BioticsSources

In June 2006, Nichimou Biotics obtained ISO 9001 certification.Sources

Transferred Nichimo's Biotics sales department to Nichimo Biotics and started a new company that manages everything from production to salesSources

In November 2007, the Biotics sales division of Nichimou was transferred to Nichimou Biotics, launching a new company that manages the entire business from production to sales.Sources

Renewed ISO9001:2008 certification at Nichimo Biotics' Shimonoseki factorySources

In June 2009, ISO 9001:2008 certification was renewed at Nichimou Biotics’ Shimonoseki plant.Sources

Launched 'Imbalance®', a non-GMO defatted soybean koji mold fermented soybean culture, as a health food ingredientSources

Launch of our proprietary supplement brand 'Imbalance + GABA'Sources

Launch of the supplement 'Dr. Imbalance' for medical institutionsSources

In December 2010, the non‑GMO, defatted soybean fermented with koji mold without salt, the koji‑fermented soybean culture "ImuBalance", was launched as a health food ingredient.Sources

In December 2010, the company’s own brand supplement "ImuBalance+GABA" was released.Sources

In December 2010, the supplement "Dr. ImuBalance" for medical institutions was released.Sources

Fermented soybean germ extract 'AglyMax®' obtained the 'Raw Material High-Quality Certification' for the first time in JapanSources

In February 2011, the fermented soybean germ extract "AglyMax" became the first in Japan to receive the "High‑Quality Raw Material" certification.Sources

Patents obtained for AglyMax® and ImmuBalance® as stem cell enhancement materialsSources

In August 2011, patents were obtained for AglyMax and ImmuBalance as stem cell‑enhancing materials.Sources

New release of 'IsoraCon Premium'Sources

In March 2012, "IsoLacon Premium" was newly released.Sources

New release of 'Kenraku Lifestyle Series'Sources

In September 2012, the "Health Life Series" was newly released.Sources

Anti-allergy material: Koji mold fermented soybean culture 'Imbalance®' obtained the 'Raw Material High-Quality Certification'Sources

In February 2013, the anti‑allergy ingredient "ImuBalance", a koji‑fermented soybean culture, received the "High‑Quality Raw Material" certification.Sources

Closure of Osaka and Fukuoka sales offices due to new sales structureSources

In April 2013, the Osaka and Fukuoka sales offices were closed under the new sales structure.Sources

New release of 'IsoraCon Folic Acid 400μg Plus'Sources

Fermented soybean culture ImmuBalance obtained a patent for hay fever improvementSources

October 2014, launch of 'IsoLacon Folic Acid 400μg Plus'.Sources

October 2014, fermented soybean culture ImmuBalance obtained a patent for hay fever improvement.Sources

New release of 'Sukkiri Meguru Aojiru'Sources

January 2015, launch of 'Sukkiri Meguru Aojiru'.Sources

Renewal of ISO9001:2015 certification at Nichimou Biotics' Shimonoseki factorySources

October 2016, ISO 9001:2015 certification renewed at Nichimou Biotics's Shimonoseki plant.Sources

Acquired Tokyo cosmetics manufacturing and sales license (permit)Sources

August 2018, obtained cosmetics manufacturing and sales license in Tokyo.Sources

New release of AD creams for the proprietary cosmetics 'Atopis' and 'Soimuribura' using Koji polysaccharides (ImmuBalance®-SE) raw materialsSources

January 2019, launch of AD creams 'Atopis' and 'Soym Libre' made from koji polysaccharide (ImmuBalance®-SE) and the company's own brand.Sources

Relocated head office to Hamamatsucho, Minato Ward, unified own mail-order products and 'Kenraku Lifestyle Series' products under the ISOLACOM brandSources

July 2019, relocated headquarters to Hamamatsu-cho, Minato-ku, and unified the company's e-commerce products and 'Kenrak Seikatsu Series' under the ISOLACOM brand.Sources

Jointly obtained a patent for a composition for improving endometriosis with Kyoto Prefectural University of MedicineSources

November 2021, jointly with Kyoto Prefectural University of Medicine, obtained a patent for a composition to improve endometriosis.Sources

Renewal of the online shop 'Isoflavone Club'Sources

February 2024, renewal of the online shop 'Isoflavone Club'.Sources

December 2024, obtained JFS-B standard certification at Nichimou Biotics's Shimonoseki plant.Sources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information4010701019904
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
ニチモウバイオティックス株式会社
Trade name (kana)
ニチモウバイオティックス
Name in English
Corporation type
301
Address
〒105-0013 東京都港区浜松町1丁目6番15号
Postal code
1050013
Prefecture code
13
City code
103
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2023-06-13
Change date
2019-07-08
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
12
Correction type
1
Trade name image ID
Address image ID
Sequence number
1771787
METI gBizINFO4010701019904
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
4010701019904
Trade name
ニチモウバイオティックス株式会社
Trade name (kana)
ニチモウバイオティックス
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
東京都港区浜松町1丁目6番15号
Postal code
1050013
Prefecture
東京都
Prefecture code
13
City or district
港区
City code
103
Street address
浜松町1丁目6番15号
Organisation type
301
Processing type
12
Correction type
1
Status
Representative
Capital
Employees
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2023-06-13
Key information
4010701019904
§09

Sources & updates

SOURCES
↑